Abingdon, United Kingdom

Michael Philip Mazanetz

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 11.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Notts, GB (2011)
  • Basingstoke, GB (2011 - 2013)
  • Abingdon, GB (2012 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Michael Philip Mazanetz

Introduction

Michael Philip Mazanetz is a notable inventor based in Abingdon, GB, with a remarkable portfolio of seven patents to his name. His work primarily focuses on advancements in the pharmaceutical field, particularly in the development of novel medicaments.

Latest Patents

Among his latest innovations are patents related to substituted naphthyridines, specifically their use as medicaments. These inventions encompass new substituted naphthyridines of formula 1, alongside pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof, where 'n' may either be 0 or 1. This substantial contribution to medicinal chemistry highlights his dedication to enhancing therapeutic solutions.

Career Highlights

Over the years, Michael has significantly impacted the pharmaceutical industry through his tenure at esteemed companies such as Eli Lilly and Company and Boehringer Ingelheim Pharma GmbH & Co. KG. His innovative spirit and commitment to research have not only advanced drug development but also reinforced the importance of intellectual property in fostering innovation.

Collaborations

Throughout his career, Michael has collaborated with several accomplished professionals, including Andrew Caerwyn Williams and Karin Briner. These partnerships have facilitated the exchange of ideas and further propelled his inventive efforts in creating valuable medicinal products.

Conclusion

Michael Philip Mazanetz exemplifies the role of an inventive mind in the pharmaceutical sector, with his contributions leading to significant advancements in medicament development. His continued dedication to innovation serves as an inspiration to both current and future inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…